• 1. Evolution of important glucosinolates in three common Brassica vegetables during their processing into vegetable powder and in vitro gastric digestion
  Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220
• 2. Estimates of hydride ion stability in condensed systems: energy of formation and solvation in aqueous and polar-organic solvents
  Craig A. Kelly,David R. Rosseinsky Phys. Chem. Chem. Phys., 2001,3, 2086-2090
• 3. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 4. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 5. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Peptidomimetics Hybrid peptides

Introduction to (S)-(4-N-Boc-amino-2-oxo-pyrrolidin-1-yl)acetic Acid (CAS No. 135415-24-6)

Chemical compounds play a pivotal role in the advancement of pharmaceutical research and development, particularly in the synthesis of novel therapeutic agents. One such compound, (S)-(4-N-Boc-amino-2-oxo-pyrrolidin-1-yl)acetic Acid, with the CAS number 135415-24-6, has garnered significant attention due to its unique structural properties and potential applications in medicinal chemistry. This compound belongs to the class of β-lactam derivatives, which are well-known for their antimicrobial and anti-inflammatory properties.

The molecular structure of (S)-(4-N-Boc-amino-2-oxo-pyrrolidin-1-yl)acetic Acid consists of a pyrrolidinone core substituted with a Boc (tert-butoxycarbonyl) protected amino group and an acetic acid moiety. This configuration makes it a versatile intermediate in the synthesis of more complex molecules, particularly in the development of protease inhibitors and other enzyme-targeted therapies. The stereochemistry of the compound, specifically the (S)-configuration at the chiral center, is crucial for its biological activity and interactions with target enzymes.

In recent years, there has been a surge in research focused on developing new treatments for chronic inflammatory diseases and infections. The β-lactam scaffold, as seen in (S)-(4-N-Boc-amino-2-oxo-pyrrolidin-1-yl)acetic Acid, has been extensively studied for its ability to modulate enzyme activity. For instance, derivatives of this compound have shown promise in inhibiting matrix metalloproteinases (MMPs), which are enzymes involved in tissue degradation and inflammation. This has led to investigations into its potential use in treating conditions such as rheumatoid arthritis and cancer-related metastasis.

Moreover, the Boc protection on the amino group provides a stable handle for further chemical modifications, allowing researchers to explore various functionalization strategies. This flexibility is particularly valuable in drug discovery pipelines, where rapid and efficient synthesis of analogs is often required. The use of protecting groups like Boc is a standard practice in organic synthesis, ensuring that reactive functional groups are isolated from one another until the desired reaction is complete.

Recent studies have also highlighted the importance of computational methods in optimizing the synthesis and properties of compounds like (S)-(4-N-Boc-amino-2-oxo-pyrrolidin-1-yl)acetic Acid. Molecular modeling techniques have been employed to predict binding affinities and interactions with biological targets, thereby accelerating the drug discovery process. These computational approaches have complemented traditional experimental methods, providing a more holistic understanding of how these compounds function at the molecular level.

The pharmaceutical industry has increasingly recognized the value of such intermediates in developing next-generation therapeutics. The ability to rapidly synthesize and modify compounds like (S)-(4-N-Boc-amino-2-oxo-pyrrolidin-1-yl)acetic Acid allows for high-throughput screening campaigns, which can identify lead compounds with desirable pharmacological properties. This has led to several clinical trials investigating derivatives of this compound for various therapeutic indications.

In conclusion, (S)-(4-N-Boc-amino-2-oxo-pyrrolidin-1-yl)acetic Acid represents a significant advancement in medicinal chemistry due to its structural versatility and potential biological activity. Its role as an intermediate in synthesizing complex molecules underscores its importance in drug development pipelines. As research continues to uncover new applications for this compound and its derivatives, it is likely to remain a cornerstone in the quest for novel therapeutic agents.

• 186031-64-1(Glycine,N-[(1,1-dimethylethoxy)carbonyl]glycyl-L-prolyl-N-(2-methylpropyl)-)
• 79839-26-2((S)-(3-N-Boc-Amino-2-Oxo-Pyrrolidin-1-Yl)-Acetic Acid)
• 64472-00-0(Glycine,N-[1-[N-[1-[N-[1-[N-[1-[N-[1-[(1,1-dimethylethoxy)carbonyl]-L-prolyl]glycyl]-L-prolyl]glycyl]-L-prolyl]glycyl]-L-prolyl]glycyl]-L-prolyl]-)
• 81135-23-1(N-(Tert-butyloxycarbonyl)-alpha-aminobutyrylsarcosine)
• 116339-45-8(2-(3-(tert-Butoxycarbonylamino)-2-oxopyrrolidin-1-yl)acetic Acid)
• 66143-41-7(Glycine, N-[1-[N-[(1,1-dimethylethoxy)carbonyl]glycyl]-L-prolyl]-)
• 51785-85-4(Glycine, N-[1-[(1,1-dimethylethoxy)carbonyl]-L-prolyl]-N-methyl-)
• 250290-80-3(1-Boc-D-prolyl-glycine)
• 51785-82-1(Boc-pro-gly-OH)
• 55301-12-7(Glycine,N-[1-[N-[1-[(1,1-dimethylethoxy)carbonyl]-L-prolyl]glycyl]-L-prolyl]-)